Nifty

:

22570.35

Sensex

:

74339.44

167.95 (0.75%)
486.50 (0.66%)

Login

Nifty
Sensex

:
:

22570.35
74339.44

167.95 (0.75%)
486.50 (0.66%)

Sun Pharma Advanced Research Company Ltd.

Pharmaceuticals & Drugs - Global

Rating :

46/99

BSE: 532872 | NSE: SPARC

Watchlist

NSE BSE

270.90

25-Apr-2024

Open
High
Low
Previous Close

270.90
283.70
270.90
285.15

Volume
Traded Value (lacs)
52 Week High
52 Week Low

14322218
39093.75
472.80
178.80

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

8,820.50
N/A
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

8,605.82
N/A
38.01

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

3.64
5.48
-1.90

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
7.19
9.66

PAT CAGR (%)

10 Years
5 Years
3 Years

-
8.88
13.77

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-8.71
-8.71
3.56

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-38.03
-30.78
-35.70

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 13.86 131.09 -89.43% 21.18 31.54 -32.85% 23.95 28.46 -15.85% 47.69 25.24 88.95%
Expenses 116.48 114.91 1.37% 112.65 94.14 19.66% 126.13 106.66 18.25% 137.26 91.78 49.55%
EBITDA -102.62 16.18 - -91.47 -62.60 - -102.18 -78.20 - -89.57 -66.54 -
EBIDTM -740.40% 12.34% -431.87% -198.48% -426.64% -274.77% -187.82% -263.63%
Other Income 6.39 0.03 21,200.00% 8.49 0.06 14,050.00% 10.19 0.18 5,561.11% 10.73 0.22 4,777.27%
Interest 0.26 2.93 -91.13% 0.26 2.86 -90.91% 0.26 1.63 -84.05% 0.21 2.22 -90.54%
Depreciation 3.16 3.13 0.96% 3.18 3.00 6.00% 3.10 2.70 14.81% 2.94 2.51 17.13%
PBT -99.65 10.15 - -86.42 -68.40 - -95.35 -82.35 - -81.99 -71.05 -
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT -99.65 10.15 - -86.42 -68.40 - -95.35 -82.35 - -81.99 -71.05 -
PATM -718.98% 7.74% -408.03% -216.87% -398.12% -289.35% -171.92% -281.50%
EPS -3.07 0.31 - -2.66 -2.11 - -2.94 -2.54 - -2.53 -2.19 -

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 13.86 0.00 0 21.18 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 116.48 0.00 0 112.65 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA -102.62 0.00 - -91.47 0.00 - 0.00 0.00 0 0.00 0.00 0
EBIDTM -740.40% 0.00% -431.87% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 6.39 0.00 0 8.49 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.26 0.00 0 0.26 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 3.16 0.00 0 3.18 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT -99.65 0.00 - -86.42 0.00 - 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT -99.65 0.00 - -86.42 0.00 - 0.00 0.00 0 0.00 0.00 0
PATM -718.98% 0.00% -408.03% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS -3.07 0.00 - -2.66 0.00 - 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 106.68 238.78 137.25 252.96 76.81 182.87 78.26 181.02 161.28 155.74 167.03 Net Sales Growth -50.69% 73.97% -45.74% 229.33% -58.00% 133.67% -56.77% 12.24% 3.56% -6.76% Cost Of Goods Sold 26.45 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Gross Profit 80.23 238.78 137.25 252.96 76.81 182.87 78.26 181.02 161.28 155.74 167.03 GP Margin 75.21% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% Total Expenditure 492.52 452.84 324.00 387.93 386.83 334.16 320.87 303.72 224.48 190.83 133.54 Power & Fuel Cost - 5.75 4.62 4.60 5.14 5.08 4.92 4.67 4.49 4.78 3.95 % Of Sales - 2.41% 3.37% 1.82% 6.69% 2.78% 6.29% 2.58% 2.78% 3.07% 2.36% Employee Cost - 107.00 98.31 91.59 93.09 81.06 100.92 84.30 56.60 45.79 40.40 % Of Sales - 44.81% 71.63% 36.21% 121.20% 44.33% 128.95% 46.57% 35.09% 29.40% 24.19% Manufacturing Exp. - 180.31 134.27 209.78 30.47 17.81 31.79 29.39 26.42 17.96 16.19 % Of Sales - 75.51% 97.83% 82.93% 39.67% 9.74% 40.62% 16.24% 16.38% 11.53% 9.69% General & Admin Exp. - 154.10 84.39 78.49 251.32 221.40 181.18 180.29 131.88 119.37 71.71 % Of Sales - 64.54% 61.49% 31.03% 327.20% 121.07% 231.51% 99.60% 81.77% 76.65% 42.93% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 5.68 2.41 3.48 6.81 8.80 2.05 5.06 5.08 2.94 0.00 % Of Sales - 2.38% 1.76% 1.38% 8.87% 4.81% 2.62% 2.80% 3.15% 1.89% 0.77% EBITDA -385.84 -214.06 -186.75 -134.97 -310.02 -151.29 -242.61 -122.70 -63.20 -35.09 33.49 EBITDA Margin -361.68% -89.65% -136.07% -53.36% -403.62% -82.73% -310.01% -67.78% -39.19% -22.53% 20.05% Other Income 35.80 10.88 6.84 5.41 9.76 13.51 4.94 13.72 2.94 3.03 10.00 Interest 0.99 7.63 13.33 10.65 2.67 0.09 0.12 1.82 2.16 0.22 5.60 Depreciation 12.38 11.77 10.16 10.92 9.48 7.55 8.18 8.24 7.58 7.24 3.57 PBT -363.41 -222.58 -203.40 -151.14 -312.40 -145.43 -245.97 -119.04 -69.99 -39.52 34.32 Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.00 Tax Rate 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 11.66% PAT -363.41 -222.58 -203.40 -151.14 -312.40 -145.43 -197.00 -119.04 -69.99 -39.52 30.32 PAT before Minority Interest -363.41 -222.58 -203.40 -151.14 -312.40 -145.43 -197.00 -119.04 -69.99 -39.52 30.32 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -340.65% -93.22% -148.20% -59.75% -406.72% -79.53% -251.73% -65.76% -43.40% -25.38% 18.15% PAT Growth 0.00% - - - - - - - - - EPS -11.20 -6.86 -6.27 -4.66 -9.63 -4.48 -6.07 -3.67 -2.16 -1.22 0.93

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 512.78 31.23 -168.25 -18.64 296.24 184.72 158.16 31.80 99.80 139.30 Share Capital 32.45 27.19 26.21 26.21 26.21 25.09 24.69 23.67 23.67 23.67 Total Reserves 480.32 -230.22 -194.46 -44.84 270.03 67.96 133.47 6.23 76.13 115.63 Non-Current Liabilities 138.41 77.43 164.59 55.85 7.20 11.98 10.36 10.02 9.72 9.45 Secured Loans 0.00 0.00 112.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 6.38 1.09 1.64 2.18 2.73 3.27 3.82 Long Term Provisions 8.14 8.15 8.63 10.23 6.11 10.34 8.18 7.30 6.37 5.48 Current Liabilities 178.95 171.43 233.35 235.36 95.04 116.11 108.03 124.84 37.15 38.79 Trade Payables 148.25 72.19 91.17 158.84 82.92 102.48 94.45 58.15 27.01 29.75 Other Current Liabilities 24.15 93.96 56.44 11.20 7.66 9.42 9.81 12.09 8.98 7.58 Short Term Borrowings 0.05 0.00 80.00 60.00 0.00 0.10 0.41 52.48 0.40 0.82 Short Term Provisions 6.49 5.28 5.75 5.31 4.46 4.10 3.35 2.12 0.77 0.64 Total Liabilities 830.14 280.09 229.69 272.57 398.48 312.81 276.55 166.66 146.67 187.54 Net Block 105.75 91.87 90.56 103.86 57.56 51.74 69.16 69.96 66.79 64.49 Gross Block 146.22 133.15 122.51 135.50 80.22 67.17 77.28 106.82 96.38 86.98 Accumulated Depreciation 40.47 41.28 31.95 31.64 22.66 15.44 8.12 36.86 29.58 22.49 Non Current Assets 375.16 208.93 166.58 205.38 141.09 137.59 118.27 98.88 83.46 76.87 Capital Work in Progress 27.00 26.37 5.23 32.07 24.13 3.27 1.47 0.87 0.02 0.76 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 64.80 67.83 70.64 69.24 59.29 82.48 47.45 27.99 16.55 11.50 Other Non Current Assets 177.61 22.87 0.15 0.20 0.12 0.10 0.19 0.07 0.09 0.11 Current Assets 454.96 71.15 63.11 67.19 257.38 175.22 158.28 66.59 62.93 110.12 Current Investments 290.90 11.66 6.43 8.49 210.58 107.57 9.65 0.00 0.00 6.50 Inventories 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Sundry Debtors 32.71 27.74 17.58 16.05 10.17 17.56 38.90 9.16 19.89 28.00 Cash & Bank 111.58 1.23 9.31 0.46 0.68 1.32 70.31 12.75 17.34 6.56 Other Current Assets 19.78 2.50 8.10 2.86 35.96 48.77 39.43 44.69 25.70 69.06 Short Term Loans & Adv. 15.80 28.02 21.70 39.33 33.39 46.73 37.48 43.35 24.27 63.34 Net Current Assets 276.02 -100.28 -170.24 -168.17 162.34 59.11 50.25 -58.24 25.79 71.33 Total Assets 830.12 280.08 229.69 272.57 398.47 312.81 276.55 166.65 146.67 187.55

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity -69.12 -208.23 -151.90 -210.81 -171.91 -182.77 -128.04 -44.21 -41.17 36.90 PBT -222.58 -203.40 -151.14 -312.40 -145.43 -245.97 -119.04 -69.99 -39.52 34.32 Adjustment 6.99 16.67 48.75 9.44 -21.77 3.82 -1.14 9.25 4.73 0.90 Changes in Working Capital 141.11 -26.05 -47.88 102.02 -0.17 20.48 12.86 30.41 -3.74 9.80 Cash after chg. in Working capital -74.48 -212.78 -150.26 -200.95 -167.38 -221.68 -107.32 -30.34 -38.53 45.03 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 5.37 4.54 -1.63 -9.86 -4.54 -10.08 -20.72 -13.87 -2.64 -8.13 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 48.98 0.00 0.00 0.00 0.00 Cash From Investing Activity -548.28 -29.17 1.56 155.35 -102.19 -104.62 -6.61 -13.08 53.00 43.59 Net Fixed Assets -13.70 -31.78 39.83 -63.22 -33.91 8.31 28.94 -11.29 -8.66 -3.01 Net Investments -279.24 -5.23 2.06 202.09 -103.01 -97.92 -9.65 0.00 6.50 90.41 Others -255.34 7.84 -40.33 16.48 34.73 -15.01 -25.90 -1.79 55.16 -43.81 Cash from Financing Activity 616.76 229.32 159.28 55.46 274.25 224.01 194.25 50.55 -1.26 -80.84 Net Cash Inflow / Outflow -0.64 -8.08 8.95 0.00 0.15 -63.38 59.60 -6.74 10.57 -0.35 Opening Cash & Equivalents 1.22 9.30 0.35 0.35 0.20 63.58 4.00 10.63 0.01 0.33 Closing Cash & Equivalent 0.58 1.22 9.30 0.35 0.35 0.20 63.58 4.00 10.63 0.01

Financial Ratios

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 15.80 -7.47 -6.42 -0.71 11.30 3.71 6.41 1.21 4.18 5.82 ROA -40.10% -79.80% -60.18% -93.11% -40.89% -66.85% -53.72% -44.68% -23.65% 15.29% ROE -143.72% 0.00% 0.00% -225.08% -74.72% -156.84% -127.40% -109.16% -33.17% 24.62% ROCE -69.44% -225.57% -254.10% -178.95% -59.95% -113.05% -94.66% -71.37% -31.74% 24.02% Fixed Asset Turnover 1.71 1.07 1.96 0.71 2.48 1.08 1.97 1.59 1.70 1.95 Receivable days 46.20 60.25 24.26 62.28 27.67 131.66 48.45 32.87 56.11 57.97 Inventory Days 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Payable days 0.00 0.00 0.00 316.55 300.15 244.72 218.01 163.03 136.14 120.80 Cash Conversion Cycle 46.20 60.25 24.26 -254.27 -272.48 -113.05 -169.56 -130.16 -80.03 -62.83 Total Debt/Equity 0.00 -0.37 -1.37 -3.59 0.01 0.02 0.02 1.94 0.04 0.04 Interest Cover -28.15 -14.26 -13.19 -115.79 -1547.78 -1596.71 -64.41 -31.45 -180.04 7.13

Top Investors:

sun pharmaceutical industries key employees benefit trust

jhunjhunwala rekha rakesh

lakshdeep investments & finance (p) ltd.

vijay mohanlal parekh

paresh mohanlal parekh

enam securities private limited

Annual Reports:

News Update:

Sun Pharma Adv. Res - Quarterly Results
5th Feb 2024, 13:49 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback